Skip to Main Content
Accessibility Overview
webinar register page
Topic
ARC Talks Webinar: An Overview of ARC’s Research Programs and Results of the Patient Community Survey
Description
In this month’s ARC Talks webinar, we invite you to hear from ARC’s research team as we start an exciting year. Kristen Hsu, Executive Director of Research, and Sabrina Rebello, Research Manager, will provide an overview of ARC's research programs, share findings from our 2022 community survey results, and highlight the future direction of ARC's research.
If you would like to learn more about ARC’s research focuses, be sure to join us!
There will be a Q and A section following the presentation.
Time
Jan 26, 2023 12:00 PM in
Eastern Time (US and Canada)
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host:
.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Jan 26, 2023 12:00 PM Eastern Time (US and Canada) Topic: ARC Talks Webinar: An Overview of ARC’s Research Programs and Results of the Patient Community Survey Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_hpN4_RyJR7af2lhYBwkI_w After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Kristen Hsu (Executive Director of Research @Amyloidosis Research Consortium) Kristen has over ten years of clinical operations experience within the pharmaceutical industry. She has a wealth of experience in managing complex global clinical trials for novel treatments of rare diseases. Kristen is building and overseeing ARC’s clinical research program and manages a prioritized portfolio of vital research. Sabrina Rebello (Research Manager @Amyloidosis Research Consortium) With an extensive background in research and epidemiology, Sabrina is skilled in the identification and quantification of health challenges using epidemiological methods. At ARC, Sabrina is responsible for designing, conducting, analyzing, and overseeing qualitative and quantitative research that seeks to better describe the various experiences of amyloidosis patients and their caregivers, as well as the impact the disease has on multiple domains of life. She also Oversees the development of a disease-specific patient reported outcome (PRO) measure for patients with amyloidosis.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-9:00) Alaska
(GMT-9:00) Juneau
(GMT-8:00) Vancouver
(GMT-8:00) Pacific Time (US and Canada)
(GMT-8:00) Tijuana
(GMT-7:00) Edmonton
(GMT-7:00) Mountain Time (US and Canada)
(GMT-7:00) Arizona
(GMT-7:00) Mazatlan
(GMT-7:00) Yukon
(GMT-6:00) Winnipeg
(GMT-6:00) Saskatchewan
(GMT-6:00) Central Time (US and Canada)
(GMT-6:00) Mexico City
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-6:00) Monterrey
(GMT-5:00) Montreal
(GMT-5:00) Eastern Time (US and Canada)
(GMT-5:00) Indiana (East)
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Acre
(GMT-4:00) Halifax
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) Atlantic Time (Canada)
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:30) Newfoundland and Labrador
(GMT-3:00) Santiago
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Greenland
(GMT-3:00) Sao Paulo
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Azores
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Dublin
(GMT+0:00) London
(GMT+0:00) Lisbon
(GMT+0:00) Nouakchott
(GMT+1:00) Belgrade, Bratislava, Ljubljana
(GMT+1:00) Sarajevo, Skopje, Zagreb
(GMT+1:00) Casablanca
(GMT+1:00) Oslo
(GMT+1:00) Copenhagen
(GMT+1:00) Brussels
(GMT+1:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+1:00) Amsterdam
(GMT+1:00) Rome
(GMT+1:00) Stockholm
(GMT+1:00) Vienna
(GMT+1:00) Luxembourg
(GMT+1:00) Paris
(GMT+1:00) Zurich
(GMT+1:00) Madrid
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+1:00) Warsaw
(GMT+1:00) Prague Bratislava
(GMT+1:00) Budapest
(GMT+2:00) Helsinki
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Sofia
(GMT+2:00) Athens
(GMT+2:00) Bucharest
(GMT+2:00) Nicosia
(GMT+2:00) Beirut
(GMT+2:00) Jerusalem
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+2:00) Kyiv
(GMT+2:00) Chisinau
(GMT+3:00) Nairobi
(GMT+3:00) Istanbul
(GMT+3:00) Damascus
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Minsk
(GMT+3:30) Tehran
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:30) Adelaide
(GMT+11:00) Canberra, Melbourne, Sydney
(GMT+11:00) Hobart
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+11:00) Lord Howe IsIand
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+13:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...